DHR Straddle Strategy
DHR (Danaher Corporation), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings.
DHR (Danaher Corporation) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $117.48B, a trailing P/E of 31.85, a beta of 0.84 versus the broader market, a 52-week range of 163.32-242.8, average daily share volume of 4.5M, a public-listing history dating back to 1978, approximately 61K full-time employees. These structural characteristics shape how DHR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.84 places DHR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. DHR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on DHR?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current DHR snapshot
As of May 15, 2026, spot at $161.24, ATM IV 30.61%, IV rank 43.10%, expected move 8.78%. The straddle on DHR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this straddle structure on DHR specifically: DHR IV at 30.61% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 8.78% (roughly $14.15 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DHR expiries trade a higher absolute premium for lower per-day decay. Position sizing on DHR should anchor to the underlying notional of $161.24 per share and to the trader's directional view on DHR stock.
DHR straddle setup
The DHR straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DHR near $161.24, the first option leg uses a $160.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DHR chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DHR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $160.00 | $6.20 |
| Buy 1 | Put | $160.00 | $4.75 |
DHR straddle risk and reward
- Net Premium / Debit
- -$1,095.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$1,051.52
- Breakeven(s)
- $149.05, $170.95
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
DHR straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on DHR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$14,904.00 |
| $35.66 | -77.9% | +$11,339.01 |
| $71.31 | -55.8% | +$7,774.01 |
| $106.96 | -33.7% | +$4,209.02 |
| $142.61 | -11.6% | +$644.02 |
| $178.26 | +10.6% | +$730.97 |
| $213.91 | +32.7% | +$4,295.97 |
| $249.56 | +54.8% | +$7,860.96 |
| $285.21 | +76.9% | +$11,425.96 |
| $320.86 | +99.0% | +$14,990.95 |
When traders use straddle on DHR
Straddles on DHR are pure-volatility plays that profit from large moves in either direction; traders typically buy DHR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
DHR thesis for this straddle
The market-implied 1-standard-deviation range for DHR extends from approximately $147.09 on the downside to $175.39 on the upside. A DHR long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current DHR IV rank near 43.10% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on DHR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, DHR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DHR-specific events.
DHR straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DHR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DHR alongside the broader basket even when DHR-specific fundamentals are unchanged. Always rebuild the position from current DHR chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on DHR?
- A straddle on DHR is the straddle strategy applied to DHR (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With DHR stock trading near $161.24, the strikes shown on this page are snapped to the nearest listed DHR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DHR straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the DHR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 30.61%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,051.52 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DHR straddle?
- The breakeven for the DHR straddle priced on this page is roughly $149.05 and $170.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DHR market-implied 1-standard-deviation expected move is approximately 8.78%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on DHR?
- Straddles on DHR are pure-volatility plays that profit from large moves in either direction; traders typically buy DHR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current DHR implied volatility affect this straddle?
- DHR ATM IV is at 30.61% with IV rank near 43.10%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.